William Harris, PhD
Professor of Medicine, Sanford School of Medicine, University of South Dakota;
President and CEO of OmegaQuant;
Dr. Harris is an internationally recognized expert on omega-3 fatty acids and how they can benefit patients with heart disease. Bill’s interest in omega-3 fatty acids began with his postdoctoral work when he published his first study on the effects of salmon oil on serum lipids in humans (1980). Since that time he has been the recipient of five NIH grants for studies on the effects of omega-3 fatty acids (EPA and DHA) on human health. He has over 190 publications relating to omega-3 fatty acids in medical literature and was an author on two American Heart Association scientific statements on fatty acids: “Fish Consumption, Fish Oil, Omega-3 Fatty Acids and Cardiovascular Disease” (2002), and “Omega-6 Fatty Acids and Risk for Cardiovascular Disease” (2009) both published in the Circulation Journal of the American Heart Association.
Bill obtained his PhD in Human Nutrition from the University of Minnesota, and did post-doctoral fellowships in Clinical Nutrition and Lipid Metabolism with Dr. Bill Connor at the Oregon Health Sciences University.